OOIR: Observatory of International Research

Papers

(The H4-Index of Journal of Neural Transmission is 28. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-11-01 to 2025-11-01.)

Article	Citations
Celebrating the career of professor Zdravko Lacković: a life in neuroscience, pharmacology, and discovery	99
Alterations in metabolites in the anterior cingulate cortex and thalamus and their associations with pain and empathy in patients with chronic mild pain: a preliminary study	93
Facets of movement disorders– a tribute to Heinz Reichmann	69
Do demographic and clinical features and comorbidities affect the risk of spread to an additional body site in functional motor disorders?	62
Current perspectives on brain circuits involved in food addiction-like behaviors	62
Proteinopathies: molecular mechanisms and diagnostic perspectives	58
Cholinergic neurotransmission in the brain of streptozotocin-induced rat model of sporadic Alzheimer’s disease: long-term follow up	57
A kynurenine pathway enzyme aminocarboxymuconate-semialdehyde decarboxylase may be involved in treatment-resistant depression, and baseline inflammation status of patients predicts treatment response:	56
Movement disorders associated with diarrhoea	55
Far from being the end of the road: taking a closer look at neuropalliative care in Parkinson’s disease	48
Distinct gait dimensions are modulated by physical activity in Parkinson's disease patients	46
Contrasting features between Tourette syndrome and secondary tic disorders	44
Stress enhances heartbeat-evoked potentials, independent of continuous or intermittent theta burst stimulation of the interoceptive brain network targeting the right supramarginal gyrus: a preliminary	44
A wearable device-enabled therapeutic approach to improve joint attention in autism spectrum disorder: a prospective pilot study	43
Eye movement study in essential tremor patients and its clinical correlates	43
Dopamine agonists in the treatment of Parkinson's disease: the show must go on	41
Neuromelanin granules of the substantia nigra: proteomic profile provides links to tyrosine hydroxylase, stress granules and lysosomes	40
Pathogenesis of Parkinson’s disease: from hints from monogenic familial PD to biomarkers	39
Sitagliptin attenuates L-dopa-induced dyskinesia by regulating mitochondrial proteins and neuronal activity in a 6-OHDA-induced mouse model of Parkinson’s disease	37
Unusual delayed and prolonged arm weakness and atrophy following botulinum toxin injection for musician’s cramp: case report	36
COMT inhibition with entacapone for patients with Parkinson’s disease and motor complications: the novelty of continuous infusion	34
Comparison of inflammatory biomarker levels in neurodegenerative proteinopathies: a case-control study	34
The spectrum of behavioral disorders in amyotrophic lateral sclerosis: current view	32
Camillo Golgi’s contributions to the anatomic basis of sensitivity in tendons	31
Unravelling head tremor mechanisms: insights from speech analysis in essential tremor and cervical dystonia	30

Botulinum toxin effects on biochemical biomarkers related to inflammation-associated head and neck chronic conditions: a systematic review of clinical research	30
Bradykinesia and rigidity modulated by functional connectivity between the primary motor cortex and globus pallidus in Parkinson’s disease	28
The role of immune and inflammatory-related indicators in cognitive dysfunction and disease severity in patients with parkinson’s disease	28